The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Studied over 36 weeks, in doses from 1.25 mg to 20 mg, patients taking amycretin experienced only "mild to moderate" ...

Shares of Danish pharmaceutical giant Novo Nordisk surged close to 14% on Friday after the company announced positive results ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/17.OJtTHmzH.js ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Twilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an ...

U.S. stocks are hanging near their all-time high on Friday as they head for the close of a second straight winning week.